SearchDictionaryMobileLogin

AB-182

Subscribe to Selected New Research on AB-182
1  relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: structure given in first source

Also Known As:
(bis(2,2-dimethylaziridinyl)phosphinyl)-N-hydroxyurethane; AB 182; NSC 200724

Bio-Agent Context: Research Results

-
Heterocyclic Compounds: 23
-
1-Ring Heterocyclic Compounds
-
Azirines
-
Aziridines: 12
*
AB-182: 1

Related Diseases

1. Experimental Leukemia

Related Drugs and Biologics

1. aziridine (ethyleneimine)

Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>